Latest Beta secretase Stories
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects.
Curcumin, a substance extracted from turmeric, prolongs life and enhances activity of fruit flies with a nervous disorder similar to Alzheimers.
Spanish researchers, led by Pedro Carmona from the Instituto de Estructura de la Materia in Madrid, have uncovered a new promising way to diagnose Alzheimer's disease more accurately.
A diametric shift in the levels of two proteins involved in folding, moving and cutting other proteins enables accumulation of the destructive brain plaque found in Alzheimer's disease.
Sluggish recycling of a protein-slicing enzyme could promote Alzheimer's disease.
One of the holy grails in diabetes research is to discover molecules that stimulate beta cell growth and to find drugs that target these molecules.
CAMBRIDGE, Mass., July 18, 2011 /PRNewswire/ -- Satori(TM) Pharmaceuticals today announced the presentation of two posters at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) taking place in Paris, France, July 16-21, 2011.
Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of Î²-amyloid (AÎ²) in the brains of animal models for Alzheimer's disease, but also results in a substantial improvement in memory deficit.
Drugs already in development to treat Alzheimer's disease may eventually be tapped for a different purpose altogether: re-growing the ends of injured nerves to relieve pain and paralysis.
Like two brothers wrestling fighting who need to be put in separate corners, a pair of protein molecules work together to speed up the toxic events of Alzheimerâ€™s disease.
- A political dynamiter.